"Ralph Moss performs a great service for those who want to know more about cancer, which includes a vast number of people both at present and likely long into the future."
Prof. Peter Pedersen, PhD
Department of Biological Chemistry, School of Medicine, Johns Hopkins University

First, Do No Harm


Moss relentlessly attempts to identify safe cancer therapies even if they conflict with the established medical opinions of the time Paraphrasing the cancer therapy pioneer Vincent T. DeVita Jr, individuals facing imminent death need to find treatments capable of keeping them alive long enough to benefit from the next generation of breakthrough agents. In my personal view Ralph Moss is one of the best professionals who is able to do that. He relentlessly attempts to identify appropriate therapies even if observations conflict with the established scientific and medical opinions of the time. For example, he was among the first who recognized the significance of oncolytic viral therapy some 20 years before it was accepted by the medical community. Notwithstanding, Moss inexorably insists to the most fundamental principle of medicine, ?First, do no harm?, therefore dares to ask questions when the benefit of a therapy does not warrant the appreciable risk of harm often associated with the treatment. Not unexpectedly, his views have several times been published by the Journal of Clinical Oncology, the official journal of the American Society of Clinical Oncology.
Testimonial By: Tibor Bakacs, MD, PhD, Hungarian Academy of Sciences


© 2016